These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 7925842)
1. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism. Richard MG; Bennett JP Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842 [TBL] [Abstract][Full Text] [Related]
2. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine. Jackson D; Abercrombie ED; Zigmond MJ J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167 [TBL] [Abstract][Full Text] [Related]
3. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296 [TBL] [Abstract][Full Text] [Related]
4. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine. Clark D; Salah RS; Galloway MP Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease. Hossain MA; Weiner N J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772 [TBL] [Abstract][Full Text] [Related]
6. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats. Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034 [TBL] [Abstract][Full Text] [Related]
8. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice]. Date I; Asari S; Nishimoto A; Felten DL No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347 [TBL] [Abstract][Full Text] [Related]
9. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS; Joyce JN Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220 [TBL] [Abstract][Full Text] [Related]
10. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597 [TBL] [Abstract][Full Text] [Related]
11. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction]. Nishi K; Kondo T; Narabayashi H No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916 [TBL] [Abstract][Full Text] [Related]
12. L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation. Borah A; Mohanakumar KP Neurochem Int; 2010 Jan; 56(2):357-62. PubMed ID: 19931335 [TBL] [Abstract][Full Text] [Related]
13. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. Snyder GL; Keller RW; Zigmond MJ J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978 [TBL] [Abstract][Full Text] [Related]
14. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. DeBoer P; Abercrombie ED J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558 [TBL] [Abstract][Full Text] [Related]
18. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337 [TBL] [Abstract][Full Text] [Related]
19. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550 [TBL] [Abstract][Full Text] [Related]
20. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Holmer HK; Keyghobadi M; Moore C; Meshul CK Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]